We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+6.64%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$13.4B
AUM Growth
+$421M
(+3.2%)
Cap. Flow
-$231M
Cap. Flow
% of AUM
-1.73%
Top 10 Holdings %
Top 10 Hldgs %
18.95%
Holding
286
New
38
Increased
90
Reduced
103
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$95.8M |
| 2 |
Mettler-Toledo International
MTD
|
+$89.4M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$66.9M |
| 4 |
Carnival Corporation Ltd
CCL
|
+$64.4M |
| 5 |
Walt Disney
DIS
|
+$62.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Steris
STE
|
+$102M |
| 2 |
Abbott
ABT
|
+$97.9M |
| 3 |
MGM Resorts International
MGM
|
+$97.5M |
| 4 |
Bank of America
BAC
|
+$90.9M |
| 5 |
Philip Morris
PM
|
+$88.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.01% |
| 2 | Healthcare | 16.54% |
| 3 | Industrials | 13.55% |
| 4 | Financials | 11.42% |
| 5 | Consumer Discretionary | 11.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Costco
COST
$422B
| $118M | 0.88% |
566,738
+191,024
| +51% | +$37.7M |
|
27
Trane Technologies
TT
$100B
| $118M | 0.88% |
1,317,473
-115,761
| -8% | -$10.2M |
|
28
Progressive
PGR
$123B
| $116M | 0.87% |
1,963,655
-398,454
| -17% | -$24.4M |
|
29
Marriott International
MAR
$98.3B
| $115M | 0.86% |
904,893
-311,550
| -26% | -$42.4M |
|
30
EOG Resources
EOG
$79.2B
| $112M | 0.83% |
897,729
-212,050
| -19% | -$24.6M |
|
|
CELG
31
DELISTED
Celgene Corp
CELG
| $112M | 0.83% |
1,405,143
-70,116
| -5% | -$5.82M |
|
32
Mastercard
MA
$502B
| $111M | 0.83% |
565,668
-16,973
| -3% | -$3.19M |
|
33
Illinois Tool Works
ITW
$82.6B
| $108M | 0.81% |
778,614
+160,405
| +26% | +$23.7M |
|
34
Celanese
CE
$4.9B
| $106M | 0.79% |
957,599
-22,550
| -2% | -$2.49M |
|
35
Broadcom
AVGO
$1.85T
| $105M | 0.78% |
4,330,790
+425,310
| +11% | +$10.4M |
|
36
United Airlines
UAL
$39.4B
| $102M | 0.76% |
1,456,228
-30,817
| -2% | -$2.14M |
|
37
S&P Global
SPGI
$121B
| $100M | 0.75% |
490,776
-13,584
| -3% | -$2.68M |
|
|
38
Thermo Fisher Scientific
TMO
$213B
| $99.7M | 0.74% |
481,460
+451,537
| +1,509% | +$95.8M |
|
|
PF
39
DELISTED
Pinnacle Foods, Inc.
PF
| $98.8M | 0.74% |
1,517,931
+91,442
| +6% | +$5.63M |
|
40
CME Group
CME
$96.3B
| $97.6M | 0.73% |
595,174
-15,552
| -3% | -$2.54M |
|
|
WP
41
DELISTED
Worldpay, Inc.
WP
| $97.3M | 0.73% |
1,189,847
+46,506
| +4% | +$3.8M |
|
42
PayPal
PYPL
$48.9B
| $94.7M | 0.71% |
1,137,145
-33,935
| -3% | -$2.7M |
|
|
CMA
43
DELISTED
Comerica
CMA
| $92.6M | 0.69% |
1,018,325
+342,884
| +51% | +$32.9M |
|
|
TSS
44
DELISTED
Total System Services, Inc.
TSS
| $91.6M | 0.68% |
1,083,333
+336,893
| +45% | +$29M |
|
45
Lennox International
LII
$14.4B
| $90.9M | 0.68% |
454,039
-8,462
| -2% | -$1.71M |
|
46
TransUnion
TRU
$15.1B
| $88.3M | 0.66% |
1,232,898
-21,204
| -2% | -$1.41M |
|
47
Avery Dennison
AVY
$13B
| $87.6M | 0.65% |
857,822
+53,133
| +7% | +$5.62M |
|
48
Aptiv
APTV
$12B
| $86.2M | 0.64% |
940,908
+33,271
| +4% | +$3.1M |
|
49
Arthur J. Gallagher & Co
AJG
$64.1B
| $85.7M | 0.64% |
1,312,960
+149,387
| +13% | +$10.1M |
|
50
TransDigm Group
TDG
$70.2B
| $84.8M | 0.63% |
245,649
-4,200
| -2% | -$1.38M |
|
Similar funds
OAG
JG
CHP
SAM
Westfield Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Westfield Capital Management held 286 positions worth $13.4B, up 3.2% from $13B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Westfield Capital Management's Q2 2018 filing shows 38 new, 90 increased, 103 reduced and 43 closed positions. Its largest new stake was Bristol-Myers Squibb: 1,238,227 shares worth $68.5M. The largest sale was Steris, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Westfield Capital Management's largest Q2 2018 buy was Bristol-Myers Squibb: 1,238,227 shares worth $68.5M.
- Westfield Capital Management added most to Thermo Fisher Scientific in Q2 2018, an estimated $95.8M increase.
- Westfield Capital Management's biggest Q2 2018 reduction was Steris, cutting an estimated $102M.
- Westfield Capital Management fully exited MGM Resorts International in Q2 2018, selling an estimated $97.5M.
- Westfield Capital Management's ten largest holdings make up 19% of its $13.4B portfolio in Q2 2018.
- Westfield Capital Management opened 38 new positions and closed 43 in Q2 2018.
- Westfield Capital Management's portfolio value rose 3.2% quarter-over-quarter to $13.4B.
Based on Westfield Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.